<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.3" -->
<?xml-stylesheet href="http://www.w3.org/2000/08/w3c-synd/style.css" type="text/css"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <title>Engineering News | Chemicals &amp; Pharmaceuticals</title>
        <description><![CDATA[Latest news on chemicals and pharmaceuticals.]]></description>
        <link>https://www.engineeringnews.co.za/page/chemicals-pharmaceuticals</link>
        <lastBuildDate>Fri, 14 Aug 2026 21:19:41 +0200</lastBuildDate>
        <generator>FeedCreator 1.7.3</generator>
        <item>
            <title>CSIR has taken responsibility for the country’s pharmaceutical innovation cluster</title>
            <link>https://www.engineeringnews.co.za/article/csir-has-taken-responsibility-for-the-countrys-pharmaceutical-innovation-cluster-2026-08-12</link>
            <description><![CDATA[Responsibility for the second phase of the national Active Pharmaceutical Ingredient (API) Innovation Cluster has been officially given to the Council for Scientific and Industrial Research (CSIR). APIs were the core components of medicines which directly produced the intended therapeutic effects. The role of the cluster was to develop and commercialise technologies for the production of small-molecule APIs.   “Central to our mandate is the expectation that our work must foster industrial development and contribute to the creation of a capable state which helps address socioeconomic challenges facing our country,” pointed out CSIR CEO Dr Thulani Dlamini. “In a world characterised by rapid technological change, no single institution can address complex national challenges such as health on its own. Meaningful and timely impact can only be achieved through partnerships that harness complementary expertise, infrastructure and collective ambition.”]]></description>
            <author>Rebecca Campbell</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Wed, 12 Aug 2026 12:06:00 +0200</pubDate>
        <a_id>727655</a_id>
        <updated>1786537964</updated>
        <published>1786529160</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001291811_resized_untitledaugust122026at0857154.jpeg</image_url>
        <image_title>Delegates from government departments, State-owned entities, academia and industry gathered at the launch of the Active Pharmaceutical Ingredient Innovation Cluster</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>AECI gearing up to invest up to R900m in Modderfontein optimisation</title>
            <link>https://www.engineeringnews.co.za/article/aeci-gearing-up-to-invest-up-to-r900m-in-modderfontein-optimisation-2026-08-11</link>
            <description><![CDATA[Mining explosives and chemicals group AECI is preparing to invest between R700-million and R900-million to modernise its historic Modderfontein facility, in Gauteng, which the group views as key to its ongoing competitiveness in southern and central Africa. CEO Alan Dickson, who took up the position on July 1, tells Engineering News & Mining Weekly that the company has already made some initial investments at the facility in a bid to improve efficiencies and raise utilisation levels.]]></description>
            <author>Terence Creamer</author>
            <category>AECI</category>
            <pubDate>Tue, 11 Aug 2026 15:55:00 +0200</pubDate>
        <a_id>727582</a_id>
        <updated>1786457167</updated>
        <published>1786456500</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001291618_resized_alandickson1022.jpeg</image_url>
        <image_title>AECI CEO Alan Dickson</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Small-scale spray dryers improve research, development and production</title>
            <link>https://www.engineeringnews.co.za/article/small-scale-spray-dryers-improve-research-development-and-production-2026-08-07</link>
            <description><![CDATA[A new generation of small-scale spray dryers has been launched by industrial equipment and solutions provider ANDRITZ. The ANDRITZ Dedert small-scale spray dryer range is designed to help customers bridge the gap between laboratory trials and industrial-scale operation. The portfolio supports product development, process optimisation, scale‑up from pilot trials to industrial validation, as well as small-scale production. Typical applications include food, dairy, nutraceuticals and chemicals. ]]></description>
            <author>Trent Roebeck</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 07 Aug 2026 00:00:00 +0200</pubDate>
        <a_id>726300</a_id>
        <updated>1784880812</updated>
        <published>1786053600</published>
        <expires>99999999999</expires>
        <editor>Nadine James</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001287321_resized_andritzdedertpilotspraydryerjuly20261022.jpeg</image_url>
        <image_title>SPRAY DRYER 
The ANDRITZ Dedert spray dryer consists of various units with a modular, skid-mounted, plug-and-play design for easy installation</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Fertiliser disruptions present  food security risks</title>
            <link>https://www.engineeringnews.co.za/article/fertiliser-disruptions-present-food-security-risks-2026-08-07</link>
            <description><![CDATA[The ongoing US-Iran war, and resulting disruption of the Strait of Hormuz, continues to  impact critical industries including fertiliser production, which could have implications for African food security, says independent research organisation Institute for Security Studies senior research consultant Dr Marvellous Ngundu. About 50% of sulphur traded globally for phosphate fertiliser passes through the Strait of Hormuz, creating a critical bottleneck even for phosphate-rich nations, such as Morocco.]]></description>
            <author>Nadine Ramdass</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 07 Aug 2026 00:00:00 +0200</pubDate>
        <a_id>726418</a_id>
        <updated>1785824973</updated>
        <published>1786053600</published>
        <expires>99999999999</expires>
        <editor>Nadine James</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001287769_resized_chemicalsfertiliserbloombergnew1022.jpg</image_url>
        <image_title>LIMITED OPTIONS Countries that have high fertiliser import dependence, combined with limited fiscal space and large rain-fed agricultural sectors, are most exposed to the long-term consequences of fertiliser supply disruptions</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Crisis exposes Africa’s vulnerabilities, opportunities</title>
            <link>https://www.engineeringnews.co.za/article/crisis-exposes-africas-vulnerabilities-opportunities-2026-08-07</link>
            <description><![CDATA[The global repercussions of the ongoing US-Iran War and the Persian Gulf crisis have exacerbated the urgency for Africa to accelerate its energy transition and industrialisation goal, says independent research organisation Institute for Security Studies senior research associate Dhesigen Naidoo. "The politics of what is happening in the Gulf is quite troubling because it goes hand in hand with the genocide in Gaza. For some parties, it functions as an alternative strategy to consolidate the impact of the genocide."]]></description>
            <author>Nadine Ramdass</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 07 Aug 2026 00:00:00 +0200</pubDate>
        <a_id>726318</a_id>
        <updated>1785828219</updated>
        <published>1786053600</published>
        <expires>99999999999</expires>
        <editor>Nadine James</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001287435_resized_dhesigennaidoo3wrcwaterresearchcommission1119dylan1022.jpeg</image_url>
        <image_title>DHESIGEN NAIDOO The Gulf crisis has the potential to serve as a catalyst for decisive actions that can benefit African countries while reducing exposure to global instabilities</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>ASP Isotopes says revenues increasing, three business units at inflection point for profitability</title>
            <link>https://www.engineeringnews.co.za/article/asp-isotopes-says-revenues-increasing-three-business-units-at-inflection-point-for-profitability-2026-08-05</link>
            <description><![CDATA[Nasdaq- and JSE-listed advanced materials company ASP Isotopes (ASPI) says all its business units are making considerable progress, group revenues are increasing and three of its business units are at an inflection point and expected to make substantial contributions to achieving profitability in the near term. In an update to shareholders before the publication of the company's second-quarter financial results, ASPI CEO and executive chairperson Paul Mann says the two divisions responsible for the majority of near to mid-term earnings before interest, taxes, depreciation and amortisation (Ebitda) targets, namely radiopharmaceutical production company PET Labs and liquefied helium (LHe) and liquefied natural gas (LNG) producer Renergen, are operating ahead of internal expectations in terms of timing and potential profitability.]]></description>
            <author>Schalk Burger</author>
            <category>FINANCIAL RESULTS</category>
            <pubDate>Wed, 05 Aug 2026 16:21:00 +0200</pubDate>
        <a_id>727276</a_id>
        <updated>1785941233</updated>
        <published>1785939660</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001290564_resized_aspceopaulmannensep251022.jpeg</image_url>
        <image_title>ASPI CEO Paul Mann</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Two South Africans on the shortlist for the 2026 Africa Prize for Engineering Innovation</title>
            <link>https://www.engineeringnews.co.za/article/two-south-africans-on-the-shortlist-for-the-2026-africa-prize-for-engineering-innovation-2026-08-04</link>
            <description><![CDATA[Two South African innovators have been shortlisted for the UK Royal Academy of Engineering’s Africa Prize for Engineering Innovation 2026. This is the continent’s richest award aimed at promoting engineering innovation and entrepreneurship that makes an impact, across sub-Saharan Africa. The first prize is £50 000, while the three finalists will get £10 000 each, and £5 000 will go to the winner of the “One to Watch” award. The total value of the prize money is £85 000. The funding of the prizes comes partly from the UK Department of Business, Innovation, Science and Trade. The finals will take place in Johannesburg in October. The two South Africans are chemical engineer and Water Quality Engineering Professor Dyllon Randall, and biomedical researcher Sincengile Ntshingila. There are 16 shortlisted candidates in total, from 11 countries.]]></description>
            <author>Rebecca Campbell</author>
            <category>SCIENCE &amp; TECHNOLOGY</category>
            <pubDate>Tue, 04 Aug 2026 23:05:00 +0200</pubDate>
        <a_id>727161</a_id>
        <updated>1785910565</updated>
        <published>1785877500</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001290175_resized_untitled04august2026at2155262.jpeg</image_url>
        <image_title>Biomedical researcher Sincengile Ntshingila</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>AfDB provides $15m to Biovac for new multi-vaccine production facility</title>
            <link>https://www.engineeringnews.co.za/article/afdb-provides-15m-to-biovac-for-new-multi-vaccine-production-facility-2026-07-27</link>
            <description><![CDATA[Development finance institution the African Development Bank (AfDB) Group has finalised a $15-million loan to biopharmaceutical company Biologicals and Vaccines Institute of South Africa (Biovac) to support a new multi-vaccine manufacturing facility in Cape Town that will significantly expand Africa’s domestic capacity to produce vaccines. The expansion programme will increase Biovac’s total yearly manufacturing capacity to 500-million doses. Biovac’s new facility is expected to be completed by 2028 and will initially produce vaccines for cholera (oral) and subsequently for polio (IPV), pneumonia (PCV) and meningitis (MenX).]]></description>
            <author>Schalk Burger</author>
            <category>VACCINE PRODUCTION</category>
            <pubDate>Mon, 27 Jul 2026 09:22:00 +0200</pubDate>
        <a_id>726486</a_id>
        <updated>1785147376</updated>
        <published>1785136920</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>dtic to host conference targeting South Africa’s essential oils market </title>
            <link>https://www.engineeringnews.co.za/article/dtic-to-host-conference-targeting-south-africas-essential-oils-market-2026-07-20</link>
            <description><![CDATA[The Department of Trade, Industry and Competition (dtic), in partnership with the Southern African Essential Oil Producers’ Association, the Swiss State Secretariat for Economic Affairs (Seco) and the UN Industrial Development Organisation (Unido), will host the Essential Oils Conference at Rosemary Hill, Pretoria East, on July 23 and 24. The conference comes at a time of growing global demand for natural ingredients, sustainable cosmetics and plant-based wellness products, providing a platform for industry stakeholders to explore opportunities to strengthen South Africa’s competitiveness in the rapidly expanding essential oils market, the dtic points out.]]></description>
            <author>Tasneem Bulbulia</author>
            <category>PHARMACEUTICALS AND STATE COMPANIES</category>
            <pubDate>Mon, 20 Jul 2026 12:57:00 +0200</pubDate>
        <a_id>726027</a_id>
        <updated>1784546795</updated>
        <published>1784545020</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001286474_resized_cosmetics1022bloomberg.jpg</image_url>
        <image_title>The conference comes at a time of growing global demand for natural ingredients, sustainable cosmetics and plant-based wellness products </image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Binder helps with dust control, briquetting﻿  and beneficiation </title>
            <link>https://www.engineeringnews.co.za/article/binder-helps-with-dust-control-briquetting-beneficiation-2026-07-17</link>
            <description><![CDATA[Mineral ore fines can create environmental concerns, such as fugitive dust, which can result in air pollution and, potentially, water pollution, owing to hazardous leachate from large waste dumps. Using a chemical binder to reduce the prevalence of mineral waste dumps and fines can supplement existing dust control measures while creating a new source of revenue by briquetting fines into a saleable product, says South African Women in Mining Association member advocate Simphiwe Damane-Mkhosana.]]></description>
            <author>Trent Roebeck</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 17 Jul 2026 00:00:00 +0200</pubDate>
        <a_id>724667</a_id>
        <updated>1784011763</updated>
        <published>1784239200</published>
        <expires>99999999999</expires>
        <editor>Nadine James</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001282306_resized_untitled30june20261022.jpeg</image_url>
        <image_title>EFFECTIVE DUST CONTROL
Using the chemical binder can supplement dust control measures, while the briquetting of fines can generate revenue</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>South African govt, industry and academia unite behind fluorochemicals programme</title>
            <link>https://www.engineeringnews.co.za/article/flourochemicals-sa-nmu-tia-sign-moa-to-advance-innovation-programme-as-plant-rfp-beckons-2026-07-03</link>
            <description><![CDATA[Flourochemicals South Africa (FSA), the Technology Innovation Agency (TIA) and Nelson Mandela University (NMU) have signed a memorandum of agreement (MoA) to advance the Fluorochemicals Strategic Innovation Programme (FSIP). The TIA is an agency of the Department of Science, Technology and Innovation.]]></description>
            <author>Irma Venter</author>
            <category>CHEMICALS</category>
            <pubDate>Fri, 03 Jul 2026 00:00:00 +0200</pubDate>
        <a_id>724099</a_id>
        <updated>1782800221</updated>
        <published>1783029600</published>
        <expires>99999999999</expires>
        <editor>Martin Zhuwakinyu</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Flourochemicals SA, NMU, TIA sign MoA to advance innovation programme as plant RFP beckons</title>
            <link>https://www.engineeringnews.co.za/article/flourochemicals-sa-nmu-tia-sign-moa-to-advance-innovation-programme-as-plant-rfp-beckons-2026-06-19</link>
            <description><![CDATA[Flourochemicals South Africa (FSA), the Technology Innovation Agency (TIA) and Nelson Mandela University (NMU) have signed a memorandum of agreement (MoA) to advance the Fluorochemicals Strategic Innovation Programme (FSIP). The TIA is an agency of the Department of Science, Technology and Innovation.]]></description>
            <author>Irma Venter</author>
            <category>CHEMICALS</category>
            <pubDate>Fri, 19 Jun 2026 13:58:00 +0200</pubDate>
        <a_id>723911</a_id>
        <updated>1781876796</updated>
        <published>1781870280</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001280035_resized_untitled21november2025at130016.jpeg</image_url>
        <image_title>NMU acting deputy vice-chancellor Dr Palesa Mothapo, TIA CEO Dr Titus Mathe and Ivan Radebe at the signing of Fluorochemicals Strategic Innovation Programme at the Coega SEZ</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Event a catalyst for industry development</title>
            <link>https://www.engineeringnews.co.za/article/event-a-catalyst-for-industry-development-2026-06-05</link>
            <description><![CDATA[Coatings For Africa 2026, a networking event for Southern Africa’s coating industry, will be held at the Sandton Convention Centre, in Johannesburg, from June 24 to 26. The event, which is hosted by events company dmg Events, in association with paint industry organisation the South African Paint Manufacturing Association, will showcase latest coatings products and solutions from 150 exhibitors from several countries, including South Africa, China and India, as well as the United Arab Emirates and Europe, says dmg events’ Coatings Group associate VP, Paddy O’Neill.]]></description>
            <author>Trent Roebeck</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 05 Jun 2026 00:00:00 +0200</pubDate>
        <a_id>721646</a_id>
        <updated>1780382592</updated>
        <published>1780610400</published>
        <expires>99999999999</expires>
        <editor>Nadine James</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001272939_resized_oocoatingsforafrica2024340may20261022.jpeg</image_url>
        <image_title>COATINGS FOR AFRICA 
The Coatings For Africa 2026 edition will showcase the latest coating product innovations and solutions from 150 exhibitors</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Coating prolongs  floor life</title>
            <link>https://www.engineeringnews.co.za/article/coating-prolongs-floor-life-2026-06-05</link>
            <description><![CDATA[An improved post-initial set applied colloidal silica – a liquid densifier that strengthens concrete from within – distributed by concrete protection supplier SprayLock Africa is strengthening the floors of numerous mining, industrial and commercial sites. The Spray-Lock Concrete Protection (SCP) Post-Placement Pozzolan (P3) silica “actively interacts with the concrete matrix, as it is designed to permanently waterproof and protect new or existing concrete by sealing capillary voids, reducing moisture migration and improving durability,” says SprayLock Africa MD Carl White.]]></description>
            <author>Halima Frost</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 05 Jun 2026 00:00:00 +0200</pubDate>
        <a_id>721755</a_id>
        <updated>1780382589</updated>
        <published>1780610400</published>
        <expires>99999999999</expires>
        <editor>Nadine James</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001273264_resized_cementconcretespraylock106261022.jpeg</image_url>
        <image_title>SPECIALISED COATING 
The SCP P3 silica coating distributed by SprayLock Africa literally strengthens concrete from within
</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Africa CDC and Aspen Pharmacare aim to boost vaccine output in Africa</title>
            <link>https://www.engineeringnews.co.za/article/africa-cdc-and-aspen-pharmacare-aim-to-boost-vaccine-output-in-africa-2026-05-12</link>
            <description><![CDATA[The African Union's public health agency and South African drugmaker Aspen Pharmacare are in talks on a long‑term framework aimed at boosting vaccine production on the continent, after the Covid‑19 pandemic exposed its overreliance on imports. Africa Centres for Disease Control and Prevention (Africa CDC) and the continent's largest pharmaceutical company said on Tuesday the talks are focused on building viable markets for vaccines produced in Africa as part of efforts to improve health security and reduce the continent's reliance on imports.]]></description>
            <author>  Reuters</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Tue, 12 May 2026 14:47:00 +0200</pubDate>
        <a_id>721091</a_id>
        <updated>1778591484</updated>
        <published>1778590020</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001271238_resized_vaccine1covid19coronavirus1022.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Aspen to release first commercial batches of locally-made human insulin </title>
            <link>https://www.engineeringnews.co.za/article/aspen-to-release-first-commercial-batches-of-locally-made-human-insulin-2026-05-05</link>
            <description><![CDATA[JSE-listed Aspen Pharmacare has received approval from the South African Health Products Regulatory Authority and will start the release of the first commercial batches of human insulin manufactured for sale in South Africa, under a previously announced agreement with Novo Nordisk. The products were manufactured at Aspen’s sterile finished dose form manufacturing facility in Gqeberha, in the Eastern Cape.]]></description>
            <author>Tasneem Bulbulia</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Tue, 05 May 2026 13:08:00 +0200</pubDate>
        <a_id>720561</a_id>
        <updated>1777980613</updated>
        <published>1777979280</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001269755_resized_aspenssvp2facilityinportelizabeth11020211022.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Adcock Ingram Critical Care, Olympus partner to expand medical innovation in Southern Africa</title>
            <link>https://www.engineeringnews.co.za/article/adcock-ingram-critical-care-olympus-partner-to-expand-medical-innovation-in-southern-africa-2026-04-24</link>
            <description><![CDATA[Adcock Ingram Critical Care (AICC), a manufacturer and supplier of hospital and critical care products in Southern Africa, and global medical technology company Olympus have entered into a strategic partnership to strengthen their focus on improving patient care. The partnership will expand access to Olympus’ advanced endoscopy solutions and broader medical and surgical technologies across South Africa and the rest of the Southern African region.]]></description>
            <author>Sabrina Jardim</author>
            <category>MEDICAL</category>
            <pubDate>Fri, 24 Apr 2026 16:15:00 +0200</pubDate>
        <a_id>720105</a_id>
        <updated>1777040371</updated>
        <published>1777040100</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001268351_resized_adcockenapril1022.jpeg</image_url>
        <image_title>Olympus Middle East and Africa VP and MD Ronald Boueri and AICC MD Colin Sheen</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>ASP Isotopes expects first shipments of nuclear medicine, electronics isotopes in 2026</title>
            <link>https://www.engineeringnews.co.za/article/asp-isotopes-expects-first-shipments-of-nuclear-medicine-electronics-isotopes-in-2026-2026-04-13</link>
            <description><![CDATA[JSE- and Nasdaq-listed advanced materials company ASP Isotopes expects to dispatch the first commercial shipments of silicon-28 (Si-28), used to produce advanced electronics, and ytterbium-176 (Yb-176), which is used in nuclear medicine procedures, and carbon-14, which is used in chemical and biological research, during this year. Further, it expects to achieve Phase 1 nameplate production from the Virginia gas project in the third quarter of this year of 58 000 cubic feet a day of liquid helium and 2 500 GJ a day of liquefied natural gas (LNG).]]></description>
            <author>Schalk Burger</author>
            <category>SPECIALTY CHEMICALS</category>
            <pubDate>Mon, 13 Apr 2026 16:38:00 +0200</pubDate>
        <a_id>719184</a_id>
        <updated>1776104027</updated>
        <published>1776091080</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>SAHPRA to monitor Citro-Soda production standards following recall</title>
            <link>https://www.engineeringnews.co.za/article/sahpra-assures-public-of-actions-to-safeguard-against-gmp-noncompliance-at-adocks-citro-soda-production-line-2026-03-24</link>
            <description><![CDATA[The South African Health Products Regulatory Authority (SAHPRA) says it will continue to monitor the implementation of actions by pharmaceutical company Adcock Ingram at its Clayville, Gauteng, production facility to ensure the facility meets the necessary good manufacturing practices (GMP) standards. This follows the recall of several batches of Citro-Soda Regular products manufactured at the facility between April 2024 and December 2025.]]></description>
            <author>Chanel de Bruyn</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Tue, 24 Mar 2026 17:00:00 +0200</pubDate>
        <a_id>717942</a_id>
        <updated>1774360294</updated>
        <published>1774364400</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <attachments><attachment><url>https://cisp.cachefly.net/assets/articles/attachments/96361_citro_soda_recall_batch_details.pdf</url><size>321002</size><title>To download a list of the affected Citro-Soda Regular products, click here</title></attachment></attachments>
        <media:group><media:content url="https://cisp.cachefly.net/assets/articles/attachments/96361_citro_soda_recall_batch_details.pdf" fileSize="321002" type="video" medium="video" expression="full"><media:description type="plain">To download a list of the affected Citro-Soda Regular products, click here</media:description></media:content></media:group>
        </item>
        <item>
            <title>Necsa to tender for new multi-purpose research reactor</title>
            <link>https://www.engineeringnews.co.za/article/necsa-to-tender-for-new-multi-purpose-research-reactor-2026-03-24</link>
            <description><![CDATA[South African nuclear energy firm Necsa will soon launch the next phase of a tender for a new multi-purpose research reactor aimed at maintaining its position as a top global exporter of medical isotopes, its CEO told Reuters on Tuesday. The isotopes, used to diagnose and treat disorders such as cancer and heart disease, are created in small nuclear reactors dedicated to science and training rather than energy generation.]]></description>
            <author>  Reuters</author>
            <category>NUCLEAR RESEARCH</category>
            <pubDate>Tue, 24 Mar 2026 14:05:00 +0200</pubDate>
        <a_id>717946</a_id>
        <updated>1774355251</updated>
        <published>1774353900</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001261524_resized_untitled20260324t140941868.jpeg</image_url>
        <image_title>General view of Safari 1 that houses the nuclear research reactor at Necsa's Pelindaba facility</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Ledwaba resigns as Cilo Cybin CFO </title>
            <link>https://www.engineeringnews.co.za/article/ledwaba-resigns-as-cilo-cybin-cfo-2026-03-09</link>
            <description><![CDATA[Reshoketswe Maggy Ledwaba has resigned as CFO and executive director of JSE-listed Cilo Cybin, effective March 31. She will, however, remain with the company until April 30 to ensure an orderly transition and handover of responsibilities, including completion of its upcoming financial reporting period.]]></description>
            <author>Tasneem Bulbulia</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Mon, 09 Mar 2026 11:48:00 +0200</pubDate>
        <a_id>716855</a_id>
        <updated>1773055691</updated>
        <published>1773049680</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001258388_resized_cilocybincannabisplantflowerroomgabrieltheron0922donna.jpg</image_url>
        <image_title>Cilo Cybin cannabis plant flower room </image_title>
        <image_width>511</image_width>
        <image_height>383</image_height>
        </item>
        <item>
            <title>South Africa seeks local production of Gilead's HIV prevention drug</title>
            <link>https://www.engineeringnews.co.za/article/south-africa-seeks-local-production-of-gileads-hiv-prevention-drug-2026-03-05</link>
            <description><![CDATA[South Africa is asking local drugmakers to start a process to make Gilead Sciences’ long-acting HIV prevention drug, lenacapavir, domestically, in a push to bring production to the region where it is most needed.   The government is working alongside international partners, including Unitaid and the United States Pharmacopoeia, to identify which local company could make the twice-yearly injection safely, effectively and affordably, and provide any support needed. They will then recommend that company to Gilead.]]></description>
            <author>  Reuters</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Thu, 05 Mar 2026 08:45:00 +0200</pubDate>
        <a_id>716610</a_id>
        <updated>1772699157</updated>
        <published>1772693100</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001257626_resized_untitled318.jpeg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Drugmaker Aspen targets Mounjaro approval in sub-Saharan Africa this year</title>
            <link>https://www.engineeringnews.co.za/article/drugmaker-aspen-targets-mounjaro-approval-in-sub-saharan-africa-this-year-2026-03-04</link>
            <description><![CDATA[Aspen Pharmacare aims to secure sub‑Saharan African approval for Eli Lilly's blockbuster weight‑loss drug Mounjaro as early as this year, its CEO said on Wednesday, capitalising on soaring regional demand for obesity treatments. South Africa-based Aspen’s push to register Mounjaro across the region signals its bid to become a key manufacturing and distribution partner for global drugmakers eyeing one of the last major untapped markets for GLP‑1 weight‑loss treatments.]]></description>
            <author>  Reuters</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Wed, 04 Mar 2026 12:03:00 +0200</pubDate>
        <a_id>716560</a_id>
        <updated>1772621542</updated>
        <published>1772618580</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001257461_resized_untitled317.jpeg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>KAP claims price component of Safripol's ethylene supply dispute with Sasol has been determined ...</title>
            <link>https://www.engineeringnews.co.za/article/kap-claims-price-component-of-safripols-ethylene-supply-dispute-with-sasol-has-been-determined-in-its-favour-2026-03-02</link>
            <description><![CDATA[JSE-listed diversified industrial holding company KAP says that, in a dispute between polymer producer and KAP subsidiary Safripol and JSE-listed energy and chemicals company Sasol about an ethylene supply agreement, the dispute about the price of ethylene has now been determined in favour of Safripol with costs, and with KAP's interpretation of the pricing principles of the supply agreement being upheld by the arbitrator. This is a significant development for Safripol, KAP says.]]></description>
            <author>Schalk Burger</author>
            <category>CHEMICALS SUPPLY</category>
            <pubDate>Mon, 02 Mar 2026 14:26:00 +0200</pubDate>
        <a_id>716356</a_id>
        <updated>1772540888</updated>
        <published>1772454360</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Printing for health  products advances</title>
            <link>https://www.engineeringnews.co.za/article/printing-for-health-products-advances-2026-02-27</link>
            <description><![CDATA[Digital printing is the preferred solution when versioning, short runs and speed of production are key factors, and has been integral to a "breakthrough" by printing solutions provider Pyrotec PackMedia in addressing South African Health Products Regulatory Authority (SAHPRA) labelling requirements, says GM Timothy Beattie. South Africa’s health and wellness market mandates that packaging for vitamins, natural supplements or homeopathic remedies aligns with SAHPRA’s complementary medicines regulations and clearly communicates essential information.]]></description>
            <author>Halima Frost</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Fri, 27 Feb 2026 00:00:00 +0200</pubDate>
        <a_id>715146</a_id>
        <updated>1771917085</updated>
        <published>1772143200</published>
        <expires>99999999999</expires>
        <editor>Nadine James</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001253325_resized_packaginglabellingpyrotecpackmedia02261022.jpeg</image_url>
        <image_title>SUFFICIENT INFO
Multipage label printing facilitates regulatory compliance</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>AECI grows Ebitda, Ebitda margin; to invest in plants and equipment in 2026</title>
            <link>https://www.engineeringnews.co.za/article/aeci-grows-ebitda-ebitda-margin-to-invest-in-plants-and-equipment-in-2026-2026-02-25</link>
            <description><![CDATA[JSE-listed mining and chemicals multinational AECI posted revenue of R32.1-billion for the year ended December 31, 2025, which was down 4% on the prior year; however, it achieved record earnings before interest, taxes, depreciation and amortisation (Ebitda) of R3.4-billion and improved its Ebitda margin to 11% from 9% in the prior year. The company has concluded most of the disposals of noncore assets, and realised R2.2-billion from these disposals during the year under review. The discontinued operations also recorded a loss for the year of R15-million, down from a R560-million loss in the prior year.]]></description>
            <author>Schalk Burger</author>
            <category>FINANCIAL RESULTS</category>
            <pubDate>Wed, 25 Feb 2026 16:44:00 +0200</pubDate>
        <a_id>716070</a_id>
        <updated>1772033669</updated>
        <published>1772030640</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001255977_resized_aeciinterimceodeanmurrayjan261022.jpg</image_url>
        <image_title>AECI interim group CEO Dean Murray</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Competition Tribunal gives its approval for BASF coatings division buyout by Bond</title>
            <link>https://www.engineeringnews.co.za/article/competition-tribunal-gives-its-approval-for-basf-coatings-division-buyout-by-bond-2026-02-23</link>
            <description><![CDATA[The Competition Tribunal of South Africa has unconditionally approved the merger in which investment company Bond UK will acquire the coatings division of chemicals company BASF. Following the merger, Bond UK will have sole control of BASF’s coatings division.]]></description>
            <author>Schalk Burger</author>
            <category>MERGERS &amp; ACQUISITIONS</category>
            <pubDate>Mon, 23 Feb 2026 11:10:00 +0200</pubDate>
        <a_id>715830</a_id>
        <updated>1771838728</updated>
        <published>1771837800</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Aimia to complete secondary listing on JSE on February 24</title>
            <link>https://www.engineeringnews.co.za/article/aimia-to-complete-secondary-listing-on-jse-on-february-24-2026-02-18</link>
            <description><![CDATA[TSX-listed diversified conglomerate Aimia has received approval from the JSE and the financial surveillance department of the South African Reserve Bank (SARB) for a secondary listing on the main board of the local stock exchange under the Chemicals: Diversified subsector, from February 24. The JSE has granted approval to Aimia for a secondary listing by way of introduction under the fast-track secondary inward listing process, and the SARB approved the secondary inward listing of Aimia on the main board of the JSE and classified the secondary inward listed common shares as domestic for exchange control purposes.]]></description>
            <author>Schalk Burger</author>
            <category>CHEMICALS</category>
            <pubDate>Wed, 18 Feb 2026 12:26:00 +0200</pubDate>
        <a_id>715549</a_id>
        <updated>1771412746</updated>
        <published>1771410360</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Harper resigns from Sasol board</title>
            <link>https://www.engineeringnews.co.za/article/harper-resigns-from-sasol-board-2026-02-17</link>
            <description><![CDATA[JSE-listed chemicals and energy company Sasol says nonexecutive director Katherine Harper has tendered her resignation for personal reasons, which the board accepted on February 16. “On behalf of the board, I wish to express our sincere appreciation to Kathy for her dedicated service over the past six years. Her thoughtful insights, professionalism and valuable perspectives have enriched the board’s deliberations and made a meaningful contribution to our work.]]></description>
            <author>Schalk Burger</author>
            <category>EXECUTIVE APPOINTMENTS</category>
            <pubDate>Tue, 17 Feb 2026 12:34:00 +0200</pubDate>
        <a_id>715458</a_id>
        <updated>1771326181</updated>
        <published>1771324440</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Aspen delivers encouraging interim performance</title>
            <link>https://www.engineeringnews.co.za/article/aspen-delivers-encouraging-interim-performance-2026-02-12</link>
            <description><![CDATA[JSE-listed Aspen Pharmacare Holdings has reported that the group delivered an encouraging performance for the first half of its current financial year, supported by the continued strong momentum in commercial pharmaceuticals and solid progress in the reshaping of its sterile finished dose form (FDF) manufacturing facilities in South Africa and France. The company notes that one-off restructuring costs of about R700-million relating to these sterile FDF manufacturing facilities have been incurred in the first half of this year and have negatively impacted on earnings per share (EPS) and headline earnings per share (HEPS).]]></description>
            <author>Sabrina Jardim</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Thu, 12 Feb 2026 15:12:00 +0200</pubDate>
        <a_id>715171</a_id>
        <updated>1770906154</updated>
        <published>1770901920</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001253401_resized_aspenssvp2facilityinportelizabeth11020211022.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Sasol warns of interim earnings plunge on the back of impairments, weak prices</title>
            <link>https://www.engineeringnews.co.za/article/sasol-warns-of-interim-earnings-plunge-on-the-back-of-impairments-weak-prices-2026-02-05</link>
            <description><![CDATA[JSE-listed Sasol has warned that its earnings for the six months ended December 31, 2025, are expected to fall sharply, with earnings per share (EPS) projected to decline by between 89% and 99% year-on-year, largely owing to weaker commodity prices and significant asset impairments. In a trading statement published on February 5, the company said EPS are expected to be between 10c and 80c, down from the EPS of R7.22 reported for the six months ended December 2024.]]></description>
            <author>Darren Parker</author>
            <category>CHEMICALS &amp; ENERGY</category>
            <pubDate>Thu, 05 Feb 2026 10:41:00 +0200</pubDate>
        <a_id>714599</a_id>
        <updated>1770283472</updated>
        <published>1770280860</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001251722_resized_sasolsecunda110221.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Ramaphosa touts his use of term ‘vaccine apartheid’ as a ‘crowning achievement’</title>
            <link>https://www.engineeringnews.co.za/article/ramaphosa-touts-his-use-of-term-vaccine-apartheid-as-a-crowning-achievement-2026-02-04</link>
            <description><![CDATA[President Cyril Ramaphosa has defended and expressed pride in his use of the term “vaccine apartheid” to describe global Covid-19 vaccine distribution, while analysts, historians and public health experts have raised concerns about the accuracy and implications of the comparison. Speaking at an event in Johannesburg on February 4, Ramaphosa said global vaccine access during the early stages of the Covid-19 pandemic represented a “most revolutionary moment”, arguing that wealthy countries in the northern hemisphere secured the vast majority of available doses and left Africa without access.]]></description>
            <author>Darren Parker</author>
            <category>PHARMACEUTICALS</category>
            <pubDate>Wed, 04 Feb 2026 16:00:00 +0200</pubDate>
        <a_id>714564</a_id>
        <updated>1770214664</updated>
        <published>1770213600</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001251622_resized_cyrilramaphosa210820231022.jpg</image_url>
        <image_title>President Cyril Ramaphosa</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Stricter regulatory scrutiny reshapes pharmaceutical logistics landscape</title>
            <link>https://www.engineeringnews.co.za/article/stricter-regulatory-scrutiny-reshapes-pharmaceutical-logistics-landscape-2026-01-26</link>
            <description><![CDATA[Heightened regulatory oversight of pharmaceutical distribution is reshaping South Africa’s logistics sector, placing increased emphasis on traceability, temperature control and secure handling across the healthcare supply chain. As compliance requirements tighten, logistics providers are being compelled to invest in specialised systems, infrastructure and skills to ensure that pharmaceutical products are distributed safely and conform with regulatory standards.]]></description>
            <author>Creamer Media Reporter  </author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Mon, 26 Jan 2026 08:00:00 +0200</pubDate>
        <a_id>713760</a_id>
        <updated>1770108684</updated>
        <published>1769407200</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>1</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001249201_resized_clement.jpg</image_url>
        <image_title>Clement Kgatla Bidvest International Logistics</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        <attachments><attachment><url>https://cisp.cachefly.net/assets/articles/attachments/96045_2026-01-19_bidvest_.mp4</url><size>177147108</size><title>Watch the At Top Level video in which Creamer Media publishing editor Martin Creamer talks to Bidvest International Logistics responsible pharmacist Clement Kgatla about the local pharmaceutical distribution landscape.</title></attachment></attachments>
        <media:group><media:content url="https://cisp.cachefly.net/assets/articles/attachments/96045_2026-01-19_bidvest_.mp4" fileSize="177147108" type="video" medium="video" expression="full"><media:description type="plain">Watch the At Top Level video in which Creamer Media publishing editor Martin Creamer talks to Bidvest International Logistics responsible pharmacist Clement Kgatla about the local pharmaceutical distribution landscape.</media:description></media:content></media:group>
<enclosure url="https://cisp.cachefly.net/assets/articles/attachments/96045_2026-01-19_bidvest_.mp4" length="177147108" type="video/mpeg" />        </item>
        <item>
            <title>Sasol reports Louisiana cracker plant restart, beneficial operation at South African destoning plant</title>
            <link>https://www.engineeringnews.co.za/article/sasol-reports-louisiana-cracker-plant-restart-beneficial-operation-at-south-african-destoning-plant-2026-01-22</link>
            <description><![CDATA[JSE-listed energy and chemicals company Sasol, reporting on its performance for the six months to December 31, 2025, says its Southern Africa destoning plant reached beneficial operation in December, while its integrated polyethylene cracker plant in Louisiana, in the US, was also restarted following an extended outage. During the period under review, Sasol remained focused on stable and reliable operational performance, while reinforcing the importance of safety in all aspects of operations.]]></description>
            <author>Schalk Burger</author>
            <category>ENERGY &amp; CHEMICALS</category>
            <pubDate>Thu, 22 Jan 2026 12:10:00 +0200</pubDate>
        <a_id>713625</a_id>
        <updated>1769079215</updated>
        <published>1769076600</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Unilever South Africa lifts local content to 80% as it moves to embed supply-chain resilience</title>
            <link>https://www.engineeringnews.co.za/article/unilever-south-africa-lifts-local-content-to-80-as-it-moves-to-embed-supply-chain-resilience-2025-12-08</link>
            <description><![CDATA[The producer of a diverse range of well-known household brands – from Sunlight soap and OMO washing powder, to Vaseline and Robertsons Spices – reports that it has increased the local content in the products it manufactures in South Africa to 80% from a level of only 40% in 2019. The brands are all produced by Unilever South Africa, which manufactures 95% of the products it sells locally.]]></description>
            <author>Terence Creamer</author>
            <category>MANUFACTURING</category>
            <pubDate>Mon, 08 Dec 2025 09:00:00 +0200</pubDate>
        <a_id>711571</a_id>
        <updated>1765188815</updated>
        <published>1765177200</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001243309_resized_justinapsey1022.jpeg</image_url>
        <image_title>Unilever South Africa MD Justin Apsey</image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>ASP Isotopes founder Mann to resume CEO, chairperson duties from January</title>
            <link>https://www.engineeringnews.co.za/article/asp-isotopes-founder-mann-to-resume-ceo-chairperson-duties-from-january-2025-12-03</link>
            <description><![CDATA[JSE- and Nasdaq-listed isotopes production company ASP Isotopes has announced that its founder and executive chairperson Paul Mann will resume his role as CEO and continue as executive chairperson with effect from January 19, 2026. On September 29, the company announced that Mann would be taking a temporary leave of absence from his CEO duties for health reasons and that the board of directors had appointed ASP Isotopes COO Robert Ainscow to serve as interim CEO, in addition to his existing duties.]]></description>
            <author>Schalk Burger</author>
            <category>EXECUTIVE APPOINTMENTS</category>
            <pubDate>Wed, 03 Dec 2025 09:43:00 +0200</pubDate>
        <a_id>711374</a_id>
        <updated>1764749865</updated>
        <published>1764747780</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Digital dentistry technology company expands its presence in South Africa</title>
            <link>https://www.engineeringnews.co.za/article/digital-dentistry-technology-company-expands-its-presence-in-south-africa-2025-11-28</link>
            <description><![CDATA[Nasdaq-listed digital orthodontics and restorative dentistry technology company Align Technology (Align) has announced that it was expanding its presence in South Africa, including the appointment of a country manager. The company has a current global customer base of more than 291 000 doctors. “South Africa presents a growth opportunity for Align Technology, with increasing digital adoption, potential for development and rising demand for orthodontic treatments, driving the expansion of innovative dentistry solutions across the region,” explained company GM Middle East and Africa Angelo Maura. “In response, we are further strengthening our presence in South Africa with the same strategic focus areas on which we’ve built Align Technology’s global success: continuous innovation, doctor-led therapy, and product superiority.”]]></description>
            <author>Rebecca Campbell</author>
            <category>MEDICAL TECHNOLOGY</category>
            <pubDate>Fri, 28 Nov 2025 15:24:00 +0200</pubDate>
        <a_id>711149</a_id>
        <updated>1764338189</updated>
        <published>1764336240</published>
        <expires>99999999999</expires>
        <editor>Creamer Media Reporter  </editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Gavi, Unicef sign deal to cut malaria vaccine price</title>
            <link>https://www.engineeringnews.co.za/article/gavi-unicef-sign-deal-to-cut-malaria-vaccine-price-2025-11-24</link>
            <description><![CDATA[Global vaccine alliance Gavi and its partner Unicef will pay 25% less for a new malaria vaccine made by the Serum Institute of India within roughly a year's time, allowing them to reach more children despite cuts in international aid. The deal will reduce the cost of the R21 vaccine to $2.99 a dose from around $4. Unicef buys the vaccines with funding from Gavi, a partnership that works with governments to immunise children in the world's poorest countries. Gavi estimates the price drop will save $90-million, which can fund 30-million more doses for up to 7-million more children over the next five years. Gavi raised $3-billion less than its target at a fundraising event earlier this year as international donors, led by the United States, focused on other priorities.]]></description>
            <author>  Reuters</author>
            <category>Chemicals &amp; Pharmaceuticals</category>
            <pubDate>Mon, 24 Nov 2025 08:46:00 +0200</pubDate>
        <a_id>710605</a_id>
        <updated>1763993498</updated>
        <published>1763966760</published>
        <expires>99999999999</expires>
        <editor>  Reuters</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001240438_resized_ebolavaccine0819reuters1022.jpg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
        <item>
            <title>Bidvest International Logistics opens new pharmaceutical warehouse at OR Tambo airport</title>
            <link>https://www.engineeringnews.co.za/article/bidvest-international-logistics-opens-new-pharmaceutical-warehouse-at-or-tambo-airport-2025-11-19</link>
            <description><![CDATA[Transport and logistics company Bidvest International Logistics (BIL) has opened a new pharmaceutical warehouse in OR Tambo International Airport, in Ekurhuleni, east of Johannesburg, to meet the country’s growing demand for efficient, compliant and resilient healthcare distribution. The facility is accredited by national regulator the South African Health Products Regulatory Authority and can handle, store and distribute Schedule 0 to 6 medicines.]]></description>
            <author>Schalk Burger</author>
            <category>PHARMACEUTICAL LOGISTICS</category>
            <pubDate>Wed, 19 Nov 2025 15:51:00 +0200</pubDate>
        <a_id>710348</a_id>
        <updated>1763564955</updated>
        <published>1763560260</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        </item>
        <item>
            <title>Itac rejects rebate on copper sulphate after confirming local supply capacity</title>
            <link>https://www.engineeringnews.co.za/article/itac-rejects-rebate-on-copper-sulphate-after-confirming-local-supply-capacity-2025-11-18</link>
            <description><![CDATA[The International Trade Administration Commission of South Africa (Itac) has declined to create a rebate provision for copper sulphate used in the manufacture of animal feed, concluding that the domestic market is already served by a local producer with sufficient capacity. Itac initiated the investigation following a request from Trade, Industry and Competition Minister Parks Tau, who raised concerns that the recent duty increase on copper sulphate from 0% to 10% could have unintended consequences for the animal feed industry, which relies on the chemical as an input.]]></description>
            <author>Darren Parker</author>
            <category>AGRICULTURE</category>
            <pubDate>Tue, 18 Nov 2025 10:05:00 +0200</pubDate>
        <a_id>710187</a_id>
        <updated>1763458124</updated>
        <published>1763453100</published>
        <expires>99999999999</expires>
        <editor>Chanel de Bruyn</editor>
        <has_video>0</has_video>
        <has_audio>0</has_audio>
        <image_url>https://cisp.cachefly.net/assets/articles/images/resized/0001239226_resized_enonlinecowfeed1120251022.jpeg</image_url>
        <image_title></image_title>
        <image_width>511</image_width>
        <image_height>287</image_height>
        </item>
    </channel>
</rss>
